Indian Pharmaceutical & Life Sciences Company

Advancing Cardio-Metabolic & Renal Care.

Zycarda Life Sciences Private Limited is an Indian pharmaceutical and nutraceutical company based in Jaipur, Rajasthan. Our portfolio focus spans cardio-metabolic, cardiovascular, renal, gastrointestinal and wellness healthcare. We use scientific evaluation, quality-conscious processes and disciplined execution to build a focused portfolio for patients, healthcare professionals and partners.

Healthcare with Purpose

A science-led approach to pharmaceutical care.

Zycarda evaluates healthcare needs and product opportunities through scientific thinking, quality consciousness and consistent execution. This approach guides our pharmaceutical and nutraceutical portfolio development across practical healthcare needs.

01

Think Scientifically

We begin with science, healthcare needs and a disciplined evaluation of where our products and capabilities can create meaningful value.

02

Build with Quality

Quality is treated as a continuous discipline rather than a final checkpoint, with an emphasis on consistency, reliability and responsible execution.

03

Keep People in Focus

We keep practical patient needs, healthcare professionals and responsible communication at the centre of our approach.

04

Think Long Term

We focus on developing a thoughtful healthcare portfolio, stronger capabilities and enduring partnerships built with substance.

Therapeutic Focus

Therapeutic focus across cardio-metabolic and renal care.

Zycarda’s pharmaceutical and nutraceutical focus includes cardiovascular and metabolic health, renal care, gastrointestinal health and everyday wellness. These areas guide product evaluation and long-term portfolio development.

01

Cardio-Metabolic Care

Zycarda’s cardio-metabolic portfolio focus includes cardiovascular healthcare and metabolic health.

02

Renal Care

Renal care is one of the therapeutic areas guiding Zycarda’s pharmaceutical portfolio and product evaluation.

03

Gastrointestinal Healthcare

Gastrointestinal healthcare and digestive wellness are part of Zycarda’s broader therapeutic focus.

04

Wellness & Nutraceuticals

Zycarda’s nutraceutical portfolio focuses on nutrition and everyday wellness needs.

About Zycarda

Building a focused pharmaceutical portfolio.

Zycarda Life Sciences Private Limited is a pharmaceutical and nutraceutical company based in Jaipur, Rajasthan, India. Our therapeutic focus includes cardio-metabolic, renal and wellness healthcare, alongside cardiovascular and gastrointestinal product areas.

We are building a focused pharmaceutical and nutraceutical portfolio supported by scientific evaluation, quality-conscious processes and disciplined execution. Our long-term approach centres on understanding healthcare needs, assessing product opportunities and developing dependable capabilities and partnerships.

View Company Profile
Scientific discipline Decisions shaped by structured scientific thinking.
Quality consciousness A continuous commitment to consistency and reliability.
Patient perspective Keeping real-world healthcare needs in focus.
Long-term thinking Building capabilities designed to compound over time.
Healthcare Products

Pharmaceutical and nutraceutical products.

Explore selected pharmaceutical and nutraceutical products from Zycarda Life Sciences, including cardiovascular and nutrition-focused healthcare products.

Zaylact nutraceutical product from Zycarda Life Sciences
Nutraceutical

Zaylact

Zaylact is an orange-flavoured nutraceutical powder combining Lactitol Monohydrate BP (10 g) and Ispaghula Husk IP (3.5 g per 15 g serving) in a patient-friendly formulation for everyday digestive wellness.

Zyrostin cardiovascular healthcare product from Zycarda Life Sciences
Cardio

Zyrostin 10

Zyrostin 10 contains Rosuvastatin Calcium 10 mg, a statin for managing high cholesterol and dyslipidaemia. Use under a healthcare professional’s guidance.

Zybtol-AM50 cardiovascular healthcare product from Zycarda Life Sciences
Cardio

Zybtol AM-50

Zybtol AM-50 combines Metoprolol Succinate Extended Release 50 mg and Amlodipine 5 mg. Metoprolol slows the heart rate, while amlodipine relaxes blood vessels; together, they help lower blood pressure. Use only as prescribed by a healthcare professional.

Science

Scientific thinking in pharmaceutical care.

Scientific evaluation, product discipline and consistent execution guide Zycarda’s pharmaceutical and nutraceutical portfolio development.

01

Evidence-led thinking

We value structured evaluation and scientific reasoning when considering healthcare products and opportunities.

02

Product discipline

Every product is considered within the wider context of healthcare need, positioning, quality and execution.

03

Consistent execution

Strong healthcare businesses are built through dependable processes and attention to operational detail.

04

Continuous learning

We remain open to learning, improving our capabilities and responding thoughtfully to evolving healthcare needs.

Quality

A quality-conscious approach to healthcare.

Zycarda takes a quality-conscious approach to pharmaceutical and nutraceutical portfolio development, product evaluation, disciplined execution and continuous improvement.

Quality Mindset

Quality consciousness is embedded into the way we think about healthcare products and operations.

Scientific Rigor

We value structured scientific evaluation and disciplined decision-making.

Patient Perspective

Practical healthcare needs remain an important reference point in our approach.

Continuous Improvement

We continuously seek better systems, stronger processes and more consistent execution.

Healthcare deserves thoughtful ambition.

Contact Zycarda Life Sciences for business enquiries about our pharmaceutical portfolio, nutraceutical products and partnership opportunities. Based in Jaipur, Rajasthan, India, we work with healthcare professionals and industry partners.

Connect with Zycarda
Scroll to Top